Next Article in Journal
Cleavage of Oligonucleotides Containing a P3’→N5’ Phosphoramidate Linkage Mediated by Single-Stranded Oligonucleotide Templates
Previous Article in Journal
Microwave-Assisted Synthesis of New N1,N4-Substituted Thiosemicarbazones
Article Menu

Article Versions

Export Article

Open AccessArticle
Molecules 2011, 16(12), 10685-10694; doi:10.3390/molecules161210685

Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation

1
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medicinal School, Sichuan University, Chengdu 610041, Sichuan, China
2
College of Chemistry and Chemical Engineering, Chongqing University of Science and Technology, Chongqing 401331, China
These authors equally contributed to this work.
*
Author to whom correspondence should be addressed.
Received: 20 November 2011 / Revised: 2 December 2011 / Accepted: 13 December 2011 / Published: 20 December 2011
(This article belongs to the Section Medicinal Chemistry)
Download PDF [364 KB, uploaded 18 June 2014]

Abstract

In a cell-based screen of novel anticancer agents, the hit compound 1a which bears a pyrazolo[3,4-d]pyrimidine scaffold exhibited high inhibitory activity against a panel of four different types of tumor cell lines. In particular, the IC50 for A549 cells was 2.24 µM, compared with an IC50 of 9.20 µM for doxorubicin, the positive control. Four synthetic routes of the key intermediate 3 of 1a were explored and 1a was prepared via route D on the gram scale for further research. Two analogs of 1a were synthesized and their preliminary structure-activity relationships were studied. Flow cytometric analysis revealed that compound 1a could significantly induce apoptosis in A549 cells in vitro at low micromolar concentrations. These results suggest that the target compound 1a and its analogs with the pyrazolo[3,4-d]pyrimidine scaffold might potentially constitute a novel class of anticancer agents, which requires further studies.
Keywords: pyrazolo[3,4-d]pyrimidine; exploratory synthesis; anticancer activity; apoptosis pyrazolo[3,4-d]pyrimidine; exploratory synthesis; anticancer activity; apoptosis
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

He, H.-Y.; Zhao, J.-N.; Jia, R.; Zhao, Y.-L.; Yang, S.-Y.; Yu, L.-T.; Yang, L. Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation. Molecules 2011, 16, 10685-10694.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top